Used as a key intermediate in the synthesis of pharmaceutical agents, particularly kinase inhibitors. It plays a role in the development of targeted cancer therapies due to its ability to selectively bind to ATP-binding sites in protein kinases. Also employed in research for inflammatory diseases and neurological disorders owing to its structural compatibility with biological targets involved in signal transduction pathways. Its scaffold is frequently modified to enhance potency, selectivity, and pharmacokinetic properties in drug design.